032. Moxifloxacin pharmacokinetics in patients with lung infection from 
non-tuberculous mycobacteria

BACKGROUND: Lung infection from non-tuberculous mycobacteria (NTM), represent a significant clinical problem due to its increased incidence and difficult management. Moxifloxacin (MXF) can play an important role in the treatment of these infections, especially when microbial resistance is an issue....

Full description

Saved in:
Bibliographic Details
Published in:J Thorac Dis
Main Authors: Manika, Katerina, Chatzika, Kalliopi, Kipourou, Maria, Lada, Martha, Zarogoulidis, Konstantinos, Kioumis, Ioannis
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2015
Subjects:
The Pan Hellenic Congress Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4332104/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB032
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items